Welcome Message

President’s invitation letter

President:
Joachim Yahalom, M.D.
Memorial Sloan Kettering Cancer Center

Vice president:
Lena Specht, M.D.
Rigshospitalet, Copenhagen University Hospital

The International Lymphoma Radiation Oncology Group (ILROG) are pleased to invite you to the 3rd ILROG Educational Conference: Radiotherapy in Modern Lymphoma Management, to be held in Tokyo on the 6th & 7th of April, 2019. The Conference will be held at the TFT HALL, Tokyo Big Sight. The faculty will include international and local leaders of lymphoma management in a multidisciplinary program.

The spirit of radiotherapy in lymphoma patient care will be shared with all in the Peter Mauch memorial lecture. The program under development will cover current perspectives and controversies on the role of radiotherapy in a broad range of lymphomas, the clinical application of the involved site concept: state of the art radiotherapy planning and treatment delivery (DIBH, IMRT, Proton therapy), pharmaceutical treatment including new immune therapy, lymphoma pathology, PET scanning, late effects, biology and other new therapies.

This meeting promises to be a unique and exciting educational opportunity for radiation oncologists, hematologists/medical oncologists, radiation therapists, physicists and nurses involving in the care of patients with hematological malignancies.

We look forward to welcoming you to Tokyo, hopefully covered with cherry blossoms, in early April 2019.

Dear Friends and Colleagues,

Local organizer:
Masahiko Oguchi, M.D.
Cancer Institute Hospital-JFCR

Welcome to the 3rd ILROG Educational Conference: Radiotherapy in Modern Lymphoma Management, to be held on the 6th & 7th of April, 2019, at the TFT HALL, Tokyo Big Sight close to the Cancer Institute Hospital of Japanese Foundation for Cancer Research CIH-JFCR in Japan. I am very pleased to extend you a warm invitation to the ILROG Tokyo meeting.

The Radiation Oncology is becoming more important field in the management of Lymphoma and Hematological malignancies with rapid development of recent medical technology. However, we have practical limitation to increase the experiences of radiation therapy in our clinical lymphoma management among the Asian countries especially in Japan.

The ILROG-Tokyo2019 aim to design the educational opportunity for especially young radiation oncologists, hematologists/medical oncologists, radiation therapists, physicists and nurses. The ILROG steering committee and council member will share their experience and knowledge of radiation therapy for Hematological malignancies in their lectures and pleased to discuss with you about detail of lymphoma radiation therapy and patient’s care in case study sessions.

The primary goal of this educational meeting could be to obtain practical skill and knowledge of radiation therapy for lymphoma, myeloma leukemia. The secondary goal for young radiation oncologists would be to obtain practical knowledge to join the decision making process in the management of patients with Hematological malignancies.

Tokyo is famous as one of the most beautiful cities and the cherry blossoms are in full bloom in spring. We sincerely hope that you will enjoy both the scientific and educational assembly of ILROG meeting 2019 and the beautiful city, Tokyo.